Items where authors include "Deodhar, A."
![[up]](/style/images/multi_up.png)
Up a levelArticle
Deodhar, A., Blauvelt, A., Lebwohl, M. et al. (13 more authors) (2024) Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials. Arthritis Research & Therapy, 26 (1). 49. ISSN 1478-6354
Ritchlin, C.T. orcid.org/0000-0002-2602-1219, Deodhar, A. orcid.org/0000-0002-2130-1246, Boehncke, W. et al. (8 more authors) (2023) Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience: Analysis of the Phase 3, Randomized, Placebo-Controlled DISCOVER-1 Study. ACR Open Rheumatology, 5 (3). pp. 149-164. ISSN 2578-5745
Conference or Workshop Item
Baraliakos, X., Bird, P., Deodhar, A. et al. (15 more authors) (2024) Associations Between Clinical Characteristics and Screening MRI Findings: Exploratory Analysis of the Ongoing Phase 4, Multicenter, Randomized, Controlled STAR Study of Biologic-Naïve Patients with PsA with MRI-Confirmed Axial Involvement. In: EULAR 2024 European Congress of Rheumatology, 12-15 Jun 2024, Vienna, Austria.
Proceedings Paper
Gladman, D.D., Mease, P.J., Bird, P. et al. (13 more authors) (2022) AB0894 Efficacy and Safety of Guselkumab in Biologic-Naïve Patients With Active Axial Psoriatic Arthritis: Study Design of a Phase 4, Randomized, Double-Blind, Placebo-Controlled Trial. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 1574-1575.
Mease, P.J., Helliwell, P., Gladman, D.D. et al. (10 more authors) (2022) POS1037 Effect Of Guselkumab, A Selective Il-23p19 Inhibitor, On Axial-Related Endpoints In Patients With Active Psa: Results From A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Through 2 Years. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 832-833.